ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,245Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 501

$424K Total Retail Price of All Prescriptions

Rank: 71 out of 501

331 Patients Receiving at Least One Drug in Part D
80% Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Idaho
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

11% of this provider’s 331 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 331 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Idaho
SIMVASTATIN 321 281 53 1 5
LISINOPRIL 318 280 53 2 4
LEVOTHYROXINE SODIUM 315 310* 42 3 1
FUROSEMIDE 303 287 39 4 8
POTASSIUM CHLORIDE 290 266 42 5 11
OMEPRAZOLE 285 224 40 6 2
HYDROCODONE-ACETAMINOPHEN 262 166 44 S3 7 3
WARFARIN SODIUM 222 211 26 8 13
GABAPENTIN 208 153 38 9 12
TRIAMTERENE-HCTZ 162 127 22 10 52
DIVALPROEX SODIUM 152 110 17 11 97
METFORMIN HCL 151 108 28 12 7
FENTANYL 142 137* 17 S2 13 39
HYDROCHLOROTHIAZIDE 142 106 24 13 10
ATORVASTATIN CALCIUM 135 116 20 15 9
AMLODIPINE BESYLATE 134 129* 27 16 6
ZOLPIDEM TARTRATE 132 81 23 17 18
TRAMADOL HCL 125 106 20 18 19
TAMSULOSIN HCL 119 119 18 19 23
METOPROLOL TARTRATE 117 112* 17 20 17
METOPROLOL SUCCINATE 105 105 14 21 16
CITALOPRAM HBR 93 72 19 22 15
ROPINIROLE HCL 84 <11 <11 23 62
BISOPROLOL-HYDROCHLOROTHIAZIDE 83 78* 16 24 107
OLANZAPINE 83 <11 <11 A 24 76
RISPERIDONE 82 <11 <11 A 26 70
AMITRIPTYLINE HCL 79 <11 <11 R 27 53
SPIRIVA 74 <11 <11 28 57
SERTRALINE HCL 73 <11 <11 29 21
LORAZEPAM 72 67* 19 B 30 28
ATENOLOL 70 65* 13 31 25
MIRTAZAPINE 69 <11 <11 32 69
CARBIDOPA-LEVODOPA 67 <11 <11 33 108
LOVASTATIN 64 50 12 34 36
LOSARTAN POTASSIUM 64 64 11 34 14
QUETIAPINE FUMARATE 61 <11 <11 A 36 59
TRAZODONE HCL 61 <11 <11 36 22
SPIRONOLACTONE 60 <11 <11 38 44
OXYBUTYNIN CHLORIDE 59 59 13 39 96
RAMIPRIL 58 <11 <11 40 118
CLONAZEPAM 58 <11 <11 B 40 40
ADVAIR DISKUS 58 <11 <11 40 48
CARVEDILOL 57 <11 <11 43 33
PROPRANOLOL HCL 52 <11 <11 44 92
OXYCODONE HCL 52 <11 <11 S2 44 55
POLYETHYLENE GLYCOL 3350 51 <11 <11 46 68
LANTUS 50 <11 <11 47 58
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.